American Society of Plastic Surgeons
Log In For Medical Professionals
 

No Increase in Complications with 'Tummy Tuck' in Obese Patients

"Tummy tuck" surgery (abdominoplasty) can be safely performed in obese patients, with no increase in complications compared to non-obese patients, reports a study in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

"Abdominoplasty, with or without concurrent liposuction, in obese patients is a safe and effective procedure with similar perioperative complication rates as the non-obese patient population," write ASPS Member Surgeon Laurence Glickman, MD, MSc, FACS, and colleagues of Long Island Plastic Surgical Group, Garden City, NY. The findings help to alleviate concerns that obese patients are at higher risk of complications after tummy tuck.

Good Outcomes and Safety of Abdominoplasty in Patients with Obesity

The study included 82 patients who underwent abdominoplasty – a popular cosmetic surgery procedure to improve the appearance of the abdomen – over a seven-year period. Twenty-one patients were classified as obese, based on an average body mass index (BMI) of 35 kilograms per square meter (kg/m2). The remaining 62 patients were classified as non-obese, average BMI 25 kg/m2.

Complication rates were compared between groups, with an average follow-up time of close to one year. Obese patients were more likely to have high blood pressure; otherwise, risk factors were similar between groups. All procedures were performed by Dr. Glickman, following the same technique. For most patients in both groups, tummy tuck surgery was combined with liposuction.

As in previous studies of abdominoplasty, there was a significant risk of complications. However, all complication rates were similar between groups. Obese patients had a higher rate of fluid collections under the skin (seromas) requiring drainage: 22.5 versus 14.2 percent. However, the difference between groups was not statistically significant.

Rates of other complications were also similar between groups, including infections, wound-healing problems (dehiscence), and blood collections under the skin (hematomas). No patient in either group developed problems with blood clots (venous thromboembolism), a more serious type of complication.

Abdominoplasty is the fifth most common cosmetic procedures in the United States, with nearly 130,000 procedures performed in 2017, according to ASPS statistics. Although widely performed, abdominoplasty carries the highest complication rate of all cosmetic procedures.

"Many surgeons elect not to perform abdominoplasty on patients with a high BMI, fearing an increased risk of perioperative complications," Dr. Glickman and coauthors write. Most previous studies of abdominoplasty in high-BMI patients have focused on those who have undergone bariatric surgery (such as gastric bypass), who are at increased risk of complications.

The findings help to clarify the "risks and rewards" of abdominoplasty in non-bariatric surgery patients with a BMI in the obese range. "Our study results suggest that patients with a BMI greater than 30 in and of itself should not be viewed as a strict contraindication to abdominoplasty," Dr. Glickman and coauthors conclude. They cite a previous study suggesting that decisions about tummy-tuck surgery should consider the individual patient's risk factors, and not be based on BMI alone.

"Plastic surgeons should evaluate patients on a case-by-case basis and patients should be counseled as to the potential perioperative risks of this procedure," the researchers add. They also emphasize the importance of discussing realistic postoperative goals with patients considering abdominoplasty.

Plastic and Reconstructive Surgery® is published by Wolters Kluwer.

Click here to read "Abdominoplasty in the Obese Patient: Risk versus Reward"

Article: "Abdominoplasty in the Obese Patient: Risk versus Reward" (doi: 10.1097/PRS.0000000000005413)

About Plastic and Reconstructive Surgery

For more than 70 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.

About ASPS

The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 8,000 member surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

Logo

Patient Care Center